These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 29556336)

  • 21. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
    Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
    Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
    Patel MM; Patel BM
    CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier.
    Tosi G; Duskey JT; Kreuter J
    Expert Opin Drug Deliv; 2020 Jan; 17(1):23-32. PubMed ID: 31774000
    [No Abstract]   [Full Text] [Related]  

  • 27. [Significant role of poloxamer in drug transport across blood-brain barrier].
    Zhang W; Fang XL
    Yao Xue Xue Bao; 2008 Sep; 43(9):890-7. PubMed ID: 19048778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules.
    Harilal S; Jose J; Parambi DGT; Kumar R; Unnikrishnan MK; Uddin MS; Mathew GE; Pratap R; Marathakam A; Mathew B
    Brain Res Bull; 2020 Jul; 160():121-140. PubMed ID: 32315731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
    Goyal K; Koul V; Singh Y; Anand A
    Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
    Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
    Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
    Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
    Rempe R; Cramer S; Qiao R; Galla HJ
    Cell Tissue Res; 2014 Mar; 355(3):717-26. PubMed ID: 24585360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.
    Zhang W; Mehta A; Tong Z; Esser L; Voelcker NH
    Adv Sci (Weinh); 2021 May; 8(10):2003937. PubMed ID: 34026447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug targeting to the brain.
    de Boer AG; Gaillard PJ
    Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
    Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
    Nanomedicine (Lond); 2014 Apr; 9(5):709-22. PubMed ID: 24827845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
    Sarkar A; Fatima I; Jamal QMS; Sayeed U; Khan MKA; Akhtar S; Kamal MA; Farooqui A; Siddiqui MH
    Curr Drug Metab; 2017; 18(2):129-137. PubMed ID: 28088890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.
    Li J; Zheng M; Shimoni O; Banks WA; Bush AI; Gamble JR; Shi B
    Adv Sci (Weinh); 2021 Aug; 8(16):e2101090. PubMed ID: 34085418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The blood-brain barrier: structure, function and therapeutic approaches to cross it.
    Tajes M; Ramos-Fernández E; Weng-Jiang X; Bosch-Morató M; Guivernau B; Eraso-Pichot A; Salvador B; Fernàndez-Busquets X; Roquer J; Muñoz FJ
    Mol Membr Biol; 2014 Aug; 31(5):152-67. PubMed ID: 25046533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes.
    Johnsen KB; Moos T
    J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.